Week In Review: BeiGene Signs $1.3B Deal For Preclinical CDK2 Inhibitor From Boston’s Ensem
MF3d Deals and Financings Beijing’s BeiGene (BGNE; HK: 06160; SHA: 688235) acquired global rights to a preclinical novel cyclin-dependent kinase ...
MF3d Deals and Financings Beijing’s BeiGene (BGNE; HK: 06160; SHA: 688235) acquired global rights to a preclinical novel cyclin-dependent kinase ...
Azrieli Group (TASE: AZRG) has confirmed in a notice to the Tel Aviv Stock Exchange the report by Reuters ...
Israeli startup firm Optibus, which has developed software program for planning and working public transport, introduced as we speak ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.